We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MLM:NYSEMartin Marietta Materials, Inc. Analysis

Data as of 2026-03-10 - not real-time

$612.52

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Martin Marietta Materials posted a disappointing earnings beat and missed revenue expectations for Q4 2025, with sales falling year‑over‑year. The RSI is in oversold territory, suggesting a short‑term technical bounce, while the MACD remains bearish, indicating lingering downside pressure. The stock is trading just above a clear support level and volatility has spiked to a high 30‑day range, though the beta remains modest, tempering market‑wide swings. A comparison of the current market price to the discounted cash‑flow estimate flags the equity as overvalued, and the forward‑looking earnings multiple remains elevated relative to peers.
Fundamentally, the company sustains a modest dividend with a low payout ratio, but carries a substantial debt load that compresses cash flow flexibility. Growth in aggregates and specialty chemicals offers a balanced exposure to both cyclical construction demand and higher‑margin specialty markets, supporting a blend investment profile. The combination of a solid dividend, resilient market position, and long‑term infrastructure demand underpins a cautiously optimistic outlook despite the near‑term valuation stretch.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI indicating potential bounce
  • Bearish MACD signaling continued pressure
  • Proximity to technical support level

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation gap between market price and DCF
  • High debt burden limiting financial flexibility
  • Stable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term infrastructure demand supporting aggregates business
  • Diversified specialty chemicals segment adding margin upside
  • Sustainable dividend offering income component

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin18.49%
P/E Ratio37.5
ROE10.16%
ROA4.99%
Debt/Equity59.87
P/B Ratio3.7
Op. Cash Flow$1.8B
Free Cash Flow$-715750016

Technical Analysis

TrendBullish
RSI34.4
Support$589.64
Resistance$710.97
MA 20$667.05
MA 50$656.23
MA 200$612.02
MACDBearish
VolumeStable
Fear & Greed Index77.38

Valuation

Fair Value$314.90
Target Price$702.46
Upside/Downside14.68%
GradeOvervalued
TypeBlend
Dividend Yield0.54%

Risk Assessment

Beta0.68
Volatility33.88%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.